GALAPAGOS NV
GLPGF$3.21B
Mid CapNASDAQBiotechnology🇺🇸North America704 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
GLPGF News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
No drugs found in this phase.
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is GALAPAGOS NV's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for GALAPAGOS NV (GLPGF) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track GLPGF biotech catalysts?→
Add GLPGF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow GALAPAGOS NV's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply